Hi @Greysaintnick, I think you misunderstood LC's comment. It...

Hi @Greysaintnick, I think you misunderstood LC's comment. It was not data will be released in 3,6,12 months' time. It was data could be released in 3, 6, 12 months' time. Or in other words, there has been no schedule set, and data will be released when data is released. The comment was made after a question at the AGM in relation to Vaxinia. I think it was a bit of a wasted question as I think we shouldn't be expecting an update until there is an update available for the cholangial carcinoma expansion cohort.

I wasn't in a position to ask a question at the AGM but if I was, I would have asked when we should expect an initial update for onCARlytics. We're overdue an update (based on guidance provided by IMU) and I hope in the very least they provide something in the quarterly report even if it's as simple as how many new patients were treated with onCARlytics last quarter. I wish they would do that across all the programs, as it is an activity during the quarter, and we see a lot of money being spent without any indication patients are actually being enrolled. (i.e. is it still open slather enrolling patients for the MAST trial, or have they stopped that aspect in favour of the expansion cohort?)